ID   ZEB1_RAT                Reviewed;        1109 AA.
AC   Q62947; Q62948;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   02-OCT-2024, entry version 170.
DE   RecName: Full=Zinc finger E-box-binding homeobox 1 {ECO:0000312|RGD:3831};
DE   AltName: Full=Transcription factor 8 {ECO:0000312|RGD:3831};
DE            Short=TCF-8 {ECO:0000312|RGD:3831};
DE   AltName: Full=Zinc finger homeodomain enhancer-binding protein {ECO:0000303|PubMed:8769566};
DE            Short=Zfhep {ECO:0000303|PubMed:8769566};
GN   Name=Zeb1 {ECO:0000312|RGD:3831}; Synonyms=Tcf8 {ECO:0000312|RGD:3831};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-1109, AND ALTERNATIVE SPLICING.
RX   PubMed=8769566; DOI=10.1089/dna.1996.15.643;
RA   Cabanillas A.M., Darling D.S.;
RT   "Alternative splicing gives rise to two isoforms of Zfhep, a zinc
RT   finger/homeodomain protein that binds T3-response elements.";
RL   DNA Cell Biol. 15:643-651(1996).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-33 AND SER-678, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Binds to E-box sequences
CC       in the immunoglobulin heavy chain enhancer as well as in the regulatory
CC       regions of many other tissue-specific genes. Represses E-cadherin
CC       promoter and induces an epithelial-mesenchymal transition (EMT) by
CC       recruiting SMARCA4/BRG1. Represses BCL6 transcription in the presence
CC       of the corepressor CTBP1. Positively regulates neuronal
CC       differentiation. Represses RCOR1 transcription activation during
CC       neurogenesis. Represses transcription by binding to the E box (5'-
CC       CANNTG-3'). In the absence of TGFB1, acts as a repressor of COL1A2
CC       transcription via binding to the E-box in the upstream enhancer region
CC       (By similarity). {ECO:0000250|UniProtKB:Q64318}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with SMARCA4/BRG1.
CC       {ECO:0000250|UniProtKB:P37275}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q64318}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Zfhep-1;
CC         IsoId=Q62947-1; Sequence=Displayed;
CC       Name=2; Synonyms=Zfhep-2;
CC         IsoId=Q62947-2; Sequence=VSP_006881;
CC   -!- PTM: Ubiquitinated, leading to degradation in a proteasome-dependent
CC       manner. Deubiquitinated by USP51, leading to stabilization.
CC       {ECO:0000250|UniProtKB:P37275}.
CC   -!- SIMILARITY: Belongs to the delta-EF1/ZFH-1 C2H2-type zinc-finger
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U51583; AAB17130.1; -; mRNA.
DR   EMBL; U51584; AAB17131.1; -; mRNA.
DR   RefSeq; NP_001295194.1; NM_001308265.1. [Q62947-1]
DR   AlphaFoldDB; Q62947; -.
DR   STRING; 10116.ENSRNOP00000024336; -.
DR   iPTMnet; Q62947; -.
DR   PhosphoSitePlus; Q62947; -.
DR   PaxDb; 10116-ENSRNOP00000024336; -.
DR   Ensembl; ENSRNOT00000024336.8; ENSRNOP00000024336.5; ENSRNOG00000017863.9. [Q62947-1]
DR   Ensembl; ENSRNOT00055018761; ENSRNOP00055015120; ENSRNOG00055011066. [Q62947-1]
DR   Ensembl; ENSRNOT00060023106; ENSRNOP00060018306; ENSRNOG00060013531. [Q62947-1]
DR   Ensembl; ENSRNOT00065035958; ENSRNOP00065028994; ENSRNOG00065021132. [Q62947-1]
DR   GeneID; 25705; -.
DR   KEGG; rno:25705; -.
DR   UCSC; RGD:3831; rat. [Q62947-1]
DR   AGR; RGD:3831; -.
DR   CTD; 6935; -.
DR   RGD; 3831; Zeb1.
DR   eggNOG; KOG3623; Eukaryota.
DR   GeneTree; ENSGT00950000183208; -.
DR   InParanoid; Q62947; -.
DR   OMA; ANYINFP; -.
DR   OrthoDB; 4266655at2759; -.
DR   PhylomeDB; Q62947; -.
DR   PRO; PR:Q62947; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; TAS:RGD.
DR   GO; GO:0048513; P:animal organ development; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0090103; P:cochlea morphogenesis; ISO:RGD.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0048598; P:embryonic morphogenesis; ISO:RGD.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0043616; P:keratinocyte proliferation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0007389; P:pattern specification process; ISO:RGD.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0010464; P:regulation of mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:0051150; P:regulation of smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0033081; P:regulation of T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0048752; P:semicircular canal morphogenesis; ISO:RGD.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 6.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR008598; Di19_Zn-bd.
DR   InterPro; IPR001356; HD.
DR   InterPro; IPR009057; Homeodomain-like_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR051574; ZnF_E-box_Homeobox.
DR   PANTHER; PTHR24391; HISTONE H4 TRANSCRIPTION FACTOR-RELATED; 1.
DR   PANTHER; PTHR24391:SF18; ZINC FINGER PROTEIN 1; 1.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 4.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; DNA-binding; Homeobox; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..1109
FT                   /note="Zinc finger E-box-binding homeobox 1"
FT                   /id="PRO_0000047234"
FT   ZN_FING         150..173
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         180..202
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         220..242
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         248..272
FT                   /note="C2H2-type 4; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   DNA_BIND        559..618
FT                   /note="Homeobox; atypical"
FT   ZN_FING         881..903
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         909..931
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         937..958
FT                   /note="C2H2-type 7; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..106
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          123..143
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          278..307
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          468..501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          525..566
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          614..711
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          834..873
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          968..1109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31..47
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        283..307
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        479..501
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        547..566
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        642..705
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        838..863
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1008..1065
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         293
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   MOD_RES         657
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   MOD_RES         664
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         671
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         678
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         680
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   MOD_RES         682
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        287
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        311
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        315
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        327
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        327
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        419
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        473
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        484
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        495
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        528
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   CROSSLNK        752
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        752
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P37275"
FT   VAR_SEQ         1..198
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006881"
SQ   SEQUENCE   1109 AA;  121627 MW;  BEFE291C8795DDA6 CRC64;
     MADGPRCKRR KQANPRRNNV TNYNTVVEAN SDSDDEDKLH IVEEESVTDA ADCEGGVPDD
     ELPTDQTVLP GGSDRAGSAK NCWQDDVKDD ECDSDAENEQ NHDPNVEEFL QQQDTAVIYP
     EAPEEDQRQG TPEASGHDDN GTPDAFSQLL TCPYCDRGYK RFTSLKEHIK YRHEKNEDNF
     SCSLCSYTFA YRTQLERHMT SHKSGREQRH VTQSGGNRKF KCTECGKAFK YKHHLKEHLR
     IHSGEKPYEC PNCKKRFSHS GSYSSHISSK KCISLMPVNG RPRSGLKTSQ CSSPSLSTSP
     GSPTRPQIRQ KIENKPLQEP LSVNQIKTEP VDYEFKPIVV ASGINCSTPL QNGVFSGGGQ
     LQATSSPQGV VQAVVLPTVG LVSPISINLS DIQNVLKVAV DGNIIRQVLE NNQASLASKE
     QEAVSASSIQ QGGHSVISAI SLPLVDQDGT TKIIINYSLE QPGQLQVVPQ NLKKENPAPP
     KSCKSEKSPE DLTVKSEKDK SFDGAADEST CLLCEDCPGD LNALPELKHY DPEHPAQPPP
     PAPATEKPES SASSAGNGDL SPSQPPLKNL LSLLKAYYAL NAQPSTEELT KIADSVNLPL
     DVVKKWFEKM QAGQIPGQSL EPPSPGPGSG NIPAKTEEQP QPVDGNEPQE DSTRGQSPLK
     MTSSPVLPVG SAINGSRSCT SSPSPLNLSS ARNPQGYSCV SEGTQEEPQV EPLDLSLPKQ
     QGELLERSTV SSVYQNSVYS VQEEPLNLSC AKKEPQKDSC VTDSEPVVNV VPPSANPINI
     AIPTVTAQLP TIVAIADQNS VPCLRALAAN KQTILIPQVA YTYSATVSPA MQEPPVKVIQ
     PNGNQDERQD TSSEGVSVED QNDSDCTPPK KKTRKAENGM YACDLCDKIF QKSSSLLRHK
     YEHTGKRPHE CGICRKAFKH KHHLIEHMRL HSGEKPYQCD KCGKRFSHSG SYSQHMNHRY
     SYCKRGAEDR DAMEQEDTGP EALPEVLPTE LVGARASPSQ ADSDERESLT REEDEDSEKE
     EEEEDKEMEE LQEDKECENP QEEEEEEEEE EEEEEEEEEE EAEEAEHEAA AAKTGGAVEE
     EAAQQAGSFQ QKASGSESKR LSEEKTNEA
//
